NexGel (NXGL) Stock Price, News & Analysis

Company Overview

NexGel, Inc. develops and manufactures high-water-content, electron-beam-crosslinked aqueous polymer hydrogels. Its products are designed to provide electrical conductivity, moisture retention, cushioning, and cooling for a range of medical, consumer, and industrial applications.

The company’s hydrogel products are used in medical electrodes for applications such as electrocardiography, neuromuscular stimulation, and defibrillation, as well as in ultrasound procedures. NexGel also supplies nonconductive hydrogels for wound care, burn care, scar treatment, and cosmetic products, along with specialized formulations for veterinary and other commercial uses.

Based in Langhorne, Pennsylvania, NexGel serves customers through business-to-business relationships with medical-device manufacturers and other product companies. The company has operated in the hydrogel industry for several decades and focuses on developing and manufacturing customized products for its customers’ specific applications.

Key Stats

• Today's Range: $0.25 to $0.27
• 50-Day Range: $0.25 to $0.57
• 52-Week Range: $0.24 to $2.89
• Volume: 48,433 shs
• Average Volume: 431,206 shs
• Market Capitalization: $2.54 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.00
• Consensus Rating: Reduce

NexGel Stock Analysis - MarketRank™

NexGel scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Reduce

Consensus Rating

NexGel has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

NexGel has a consensus price target of $2.00, representing about 652.4% upside from its current price of $0.27.

Amount of Analyst Coverage

NexGel has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of NexGel is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NexGel is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

NexGel has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.06% of the float of NexGel has been sold short.

Short Interest Ratio / Days to Cover

NexGel has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NexGel has recently increased by 47.31%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NexGel does not currently pay a dividend.

Dividend Growth

NexGel does not have a long track record of dividend growth.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: N/A

News Sentiment

NexGel has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for NexGel this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, NexGel insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,950.00 in company stock.

Percentage Held by Insiders

19.79% of the stock of NexGel is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

2.21% of the stock of NexGel is held by institutions.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 9/21/2026
• Investor update: 9/24/2026
• Next Earnings (Estimated): 11/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:NXGL
• CIK: 1468929
• Web: nexgel.com
• Phone: 215-702-8550
• Fax: N/A
• Employees: 19
• Year Founded: 1974

Price Target and Rating

• Average Price Target for NexGel: $2.00
• High Price Target: $2.00
• Low Price Target: $2.00
• Potential Upside/Downside: +651.9%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.71)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3 million
• Net Margins: -51.26%
• Pretax Margin: -50.16%
• Return on Equity: -121.18%
• Return on Assets: -41.15%

Debt

• Debt-to-Equity Ratio: 0.68
• Current Ratio: 0.43
• Quick Ratio: 0.27

Sales & Book Value

• Annual Sales: $12.07 million
• Price / Sales: 0.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.60 per share
• Price / Book: 0.44

Miscellaneous

• Outstanding Shares: 9,748,000
• Free Float: 7,819,000
• Market Cap: $2.59 million
• Optionable: Not Optionable
• Beta: 0.76